These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6099754

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
    Smith BR, LeFrock JL, McCloskey RV, Donato JB, Weber SJ, Joseph WS.
    Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA, Day GJ, Humble MW.
    N Z Med J; 1982 Jun 23; 95(710):414-6. PubMed ID: 6810246
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparative study of the in vitro antibacterial activity of cefoxitin, cefuroxine, and cephaloridine.
    Norrby R, Brorsson JE, Seeberg S.
    Antimicrob Agents Chemother; 1976 Mar 23; 9(3):506-10. PubMed ID: 1259406
    [Abstract] [Full Text] [Related]

  • 32. In vitro activity of cefixime: correlation index between MIC and disc diffusion test.
    Focà A, Liberto MC, Berlinghieri MC, Matera G, Puccio R, Carbone M, Fera MT.
    Drugs Exp Clin Res; 1990 Mar 23; 16(4):175-9. PubMed ID: 2076653
    [Abstract] [Full Text] [Related]

  • 33. [Analysis of susceptibility of bacteria isolated from clinical material to cefuroxime, ceftazidime and cefotaxime].
    Giedrys-Kalemba S, Bilska I.
    Med Dosw Mikrobiol; 1993 Mar 23; 45(2):173-6. PubMed ID: 8309292
    [Abstract] [Full Text] [Related]

  • 34. Susceptibility of clinical isolates to cephalexin, cefazolin and cefotaxime.
    Gupta BL, Tahlan A, Dogra V, Rattan A, Bhujwala RA, Shriniwas.
    Indian Pediatr; 1989 May 23; 26(5):466-71. PubMed ID: 2599615
    [Abstract] [Full Text] [Related]

  • 35. In vitro activity of ceftazidime, cefotaxime and gentamicin against 11,521 clinical isolates of bacteria.
    Steinbakk M, Midtvedt T, Lingaas E, Gardsjord G.
    Acta Pathol Microbiol Immunol Scand B; 1987 Dec 23; 95(6):337-46. PubMed ID: 3326398
    [Abstract] [Full Text] [Related]

  • 36. Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics.
    Jacobus NV, Tally FP, Barza M, Gorbach SL.
    Clin Ther; 1980 Dec 23; 3(Spec Issue):34-8. PubMed ID: 6446396
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Antibacterial activity of HR-756, cefoxitin and cefuroxine against multiply antibiotic-resistant strains of Enterobacteriaceae and Pseudomonas aeruginosa.
    Legakis NJ, Kafetzis DA, Papadatos CJ, Papavassiliou JT.
    Chemotherapy; 1980 Dec 23; 26(5):334-43. PubMed ID: 6248301
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.